Social Participation Program for Older Adults in Nursing Homes
Launched by FUJIAN MEDICAL UNIVERSITY · Jul 14, 2025
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study aims to evaluate the feasibility and effectiveness of a multi-level social participation intervention among older adults residing in nursing homes, based on the Social Ecological Model (SEM). Against the backdrop of accelerated aging and rising dementia prevalence in institutional settings, the intervention seeks to enhance social engagement and mitigate cognitive decline through a structured, multi-dimensional approach.
A total of 120 older adults aged 60 years and above will be recruited from nursing homes and randomly assigned to either the intervention group or a health educ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 60 years or older
- • Basic comprehension and verbal communication abilities
- • Resided in a long-term care facility for at least one month
- Exclusion Criteria:
- • Clinically diagnosed with dementia (based on DSM-IV-R criteria)
- • Presence of severe physical illness or psychiatric disorder
- • Significant visual or hearing impairments that may interfere with accurate cognitive assessment
About Fujian Medical University
Fujian Medical University is a prestigious academic institution located in Fujian Province, China, dedicated to advancing medical education, research, and clinical practice. With a strong emphasis on innovative healthcare solutions, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient outcomes. Its comprehensive research programs are supported by a team of experienced professionals and state-of-the-art facilities, enabling the university to contribute significantly to the global medical community. Through its commitment to excellence and collaboration, Fujian Medical University aims to enhance the quality of healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fuzhou, Fujian, China
Patients applied
Trial Officials
Hong Li
Principal Investigator
Fujian Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported